Ares Financial Consulting’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8K Sell
97
-12
-11% -$2K 0.01% 483
2026
Q1
$22.6K Buy
109
+86
+374% +$21.6K 0.02% 370
2025
Q4
$6.54K Buy
+23
New +$7.19K 0.01% 426

Other funds holding PODD

Ares Financial Consulting's PODD Position: Q2 2026 in Review

Ares Financial Consulting reduced its Insulet (PODD) stake by 11% in Q2 2026, selling an estimated $2K and leaving 97 shares worth $14.8K. The position accounts for 0.01% of the portfolio, ranked #483.

Ares Financial Consulting first reported a position in PODD in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.6K in Q1 2026. 307 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Ares Financial Consulting held 97 shares of Insulet worth $14.8K as of Q2 2026.
  • Ares Financial Consulting sold 12 Insulet shares in Q2 2026, an estimated $2K.
  • Insulet made up 0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #483 holding.
  • Ares Financial Consulting first reported a position in Insulet in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Insulet position peaked at $22.6K in Q1 2026.
  • 307 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.